Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

727
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
727
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

525
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
525
Depression: Overview01:18

Depression: Overview

715
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
715
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

388
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
388
Long-term Depression01:03

Long-term Depression

3.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.0K
Long-term Depression01:05

Long-term Depression

32.9K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
32.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Boosting current generation in microbial fuel cells by an order of magnitude by coating an ionic liquid polymer on carbon anodes.

Biosensors & bioelectronics·2017
Same author

In vivo direct reprogramming of liver cells to insulin producing cells by virus-free overexpression of defined factors.

Endocrine journal·2017
Same author

Super-resolution Visualization of Caveola Deformation in Response to Osmotic Stress.

The Journal of biological chemistry·2017
Same author

Innocent But Deadly: Nontoxic Organoiridium Catalysts Promote Selective Cancer Cell Death.

ChemMedChem·2017
Same author

Interactome Analysis Reveals a Novel Role for RAD6 in the Regulation of Proteasome Activity and Localization in Response to DNA Damage.

Molecular and cellular biology·2016
Same author

Effect of statins type on incident prostate cancer risk: a meta-analysis and systematic review.

Asian journal of andrology·2016

Related Experiment Video

Updated: Jan 2, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

4.0K

Internet-Based Management for Depressive Disorder.

Zuowei Wang1, Zhiang Niu2, Lu Yang2

  • 1Hongkou District Mental Health Center, Shanghai, 200083, China. wzwhk@163.com.

Advances in Experimental Medicine and Biology
|December 1, 2019
PubMed
Summary

Artificial intelligence (AI) and electronic measurement-based care (eMBC) are transforming mental healthcare, particularly for depression. These technologies enhance patient monitoring and support clinical decision-making for psychiatrists and psychotherapists.

Keywords:
Artificial intelligence (AI)Depressive disorderMeasurement-Based Care (MBC)Therapy

More Related Videos

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.2K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.1K

Related Experiment Videos

Last Updated: Jan 2, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

4.0K
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.2K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.1K

Area of Science:

  • Digital mental health
  • Psychiatric technology
  • Clinical informatics

Background:

  • Internet advancements are reshaping psychiatric and psychotherapy roles.
  • Growing interest in artificial intelligence (AI) and electronic measurement-based care (eMBC) for treating depressive disorder.

Purpose of the Study:

  • To explore the evolving roles of mental health professionals due to technological advancements.
  • To highlight the potential applications of AI and eMBC in psychiatric practice and depressive disorder treatment.

Main Methods:

  • AI applications in population health management and patient administration.
  • AI's role in assisting clinical decision-making for physicians.
  • eMBC implementation via web/mobile devices and telephone consulting for disease monitoring.
  • Customization of eMBC interfaces within electronic medical record systems (EMRs).

Main Results:

  • AI can optimize patient administration and population health strategies.
  • AI tools offer decision support for clinicians in real-world settings.
  • eMBC enhances traditional measurement-based care through digital platforms.
  • Integration of eMBC into EMRs facilitates customized patient monitoring.

Conclusions:

  • AI and eMBC represent significant advancements in mental healthcare delivery.
  • These technologies are poised to augment the capabilities of psychiatrists and psychotherapists.
  • The integration of AI and eMBC promises improved patient management and treatment outcomes for depressive disorders.